Global Blood Processing Devices and Consumables Market Size (2024 - 2029)

The blood processing devices and consumables market is anticipated to experience growth, driven by an increasing demand due to the rising burden of disorders requiring blood transfusions and surgical treatments. The market's expansion is further supported by initiatives in regenerative medicine and cell therapies, as well as an aging population. Although the COVID-19 pandemic initially negatively impacted the market by reducing demand for blood processing due to canceled surgeries, the subsequent recovery and increased surgical procedures are expected to positively influence market size. However, challenges such as stringent regulations and high costs of devices may hinder growth.

Market Size of Global Blood Processing Devices and Consumables Industry

Blood Processing Devices and Consumables Market Size
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 6.50 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

Global Blood Processing Devices and Consumables Market Major Players

*Disclaimer: Major Players sorted in no particular order

Blood Processing Devices & Consumables Market Analysis

The blood processing devices and consumables market is expected to register a CAGR of nearly 6.5% over the forecast period (2022-2027).

The COVID-19 pandemic has significantly impacted the blood processing devices and consumables market. The onset of the COVID-19 pandemic led to a reduction in demand for blood processing because surgical procedures were canceled across the globe. For instance, as per an October 2020 published study titled, "Elective Surgery Cancellations Due to the COVID-19 pandemic: Global Predictive Modeling to Inform Surgical Recovery Plans", it was estimated that 28,404,603 operations would be canceled or postponed during the peak 12 weeks of disruption due to COVID-19. As blood transfusion procedures and other surgeries require processed blood, this had a short-term negative impact on the market across the globe.

However, with the introduction of vaccines and the upliftment of restrictions on COVID-19, the number of surgical procedures is expected to increase, and the demand for blood processing is expected to grow in the coming period, which has led several organizations to adopt various measures that can benefit the market growth. For instance, in February 2021, the World Health Organization (WHO) emphasized the importance of being prepared and responding quickly and outlined key actions and measures that the blood services should take to mitigate the potential risk to the safety and sufficiency of the blood supplies during the pandemic. Additionally, as per an April 2022 published article titled, "The Impact of COVID-19 on Blood Transfusion Services: A Systematic Review and Meta-Analysis", blood centers should focus more on launching initiatives and policies that would increase their countries' blood supply as the virus has no direct threat to blood safety. This reflects the demand for blood processing products is expected to increase. Hence, the COVID-19 pandemic is expected to have a positive impact on the market in the coming period.

The major factors fueling the market growth are the growing burden of disorders requiring blood transfusion and surgical treatment, the growing number of initiatives in regenerative medicine and cell therapies as well as increasing geriatric population.

The growing burden of disorders requiring blood transfusion is driving the market growth as per a March 2021 update by the Centers for Disease Control and Prevention (CDC). People with inherited blood disorders such as thalassemia often require frequent blood transfusions to remain healthy. The source states that red blood cell transfusions are an important part of medical care for many people with thalassemia. For instance, as per a September 2020 published article titled, "Changing Patterns in the Epidemiology of β-thalassemia," the prevalence of β-thalassemia is increasing in other regions, including Northern Europe and North America, primarily due to migration. Thus, the increasing burden of such disorders is driving the demand for blood processing products.

Additionally, the growing number of disorders requiring surgeries such as orthopedic surgeries, cardiac surgeries, and spinal surgeries is contributing to the market growth. For instance, according to British Heart Foundation's February 2021 report, in 2020, in England, about 371,000 heart procedures and operations were performed, while in 2019, about 473,000 procedures were performed. Thus, the demand for blood processing products is increasing, thereby contributing to the market growth. Moreover, as per the research study published in September 2019, titled "Rates of Total Joint Replacement in the United States: Future Projections to 2020-2040 Using the National Inpatient Sample", if the current trend continues, then there may be a significant increase in the total hip arthroplasty (THA) and total knee arthroplasty (TKA) over the years, and by 2030, the projected count for primary THA maybe 572,000 and 3.5 million primary TKA. Thus, the growing burden of surgeries increases the need for blood processing devices and consumables.

Moreover, in October 2021, Terumo Blood and Cell Technologies, a United States-based medical technology company, inaugurated its newest manufacturing facility in La Lima, Cartago, Costa Rica. The USD 60 million, world-class manufacturing plant aligns with the company's mission of Contributing to Society through Healthcare and serving more patients. The company manufactures medical devices and products that are used to collect, separate, manufacture, and process blood and cells. Similarly, in March 2021, Grifols, a global leader in the development of plasma-derived therapies and leader in the development of innovative diagnostic solutions, reported its first-ever installation in North America of the DG Reader Net semi-automated analyzer, used to facilitate pre-transfusion blood type compatibility testing. This platform, the newest addition to the company's scalable solutions for blood banks, is now running at ThedaCare Medical Center-Wild Rose in Wisconsin.

However, stringent regulations and the high cost of blood processing devices are the major factors restraining the market growth.

Blood Processing Devices & Consumables Industry Segmentation

As per the scope of the report, blood processing devices and consumables are the products used for the processing of blood so that it can be preserved and kept pathogen-free for blood or its components to be used and when during blood transfusion procedures and surgeries. The market is segmented by product (blood processing devices (blood bank freezers, blood grouping analyzers, blood warmers, blood cell processors, and other blood processing devices), and blood processing consumables (blood bags, blood lancets, vials, blood administration sets, and other blood processing consumables)), end users (hospitals and clinics, diagnostic laboratories and other end users) and geography (North America, Europe, Asia-Pacific, Middle-East and Africa and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product
By Blood Processing Devices
Blood Bank Freezers
Blood Grouping Analyzers
Blood Warmer
Blood Cell Processers
Other Blood Processing Devices
By Blood Processing Consumables
Blood Bags
Blood Lancets
Vials
Blood Administration Sets
Other Blood Processing Consumables
By End User
Hospitals and Clinics
Diagnostic Laboratories
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Blood Processing Devices and Consumables Market Size Summary

The blood processing devices and consumables market is poised for substantial growth, driven by an increasing demand for blood transfusions and surgical procedures. The market experienced a temporary setback due to the COVID-19 pandemic, which led to a reduction in surgical procedures and, consequently, a decreased demand for blood processing. However, with the easing of restrictions and the resumption of elective surgeries, the market is expected to recover and expand. Key factors contributing to this growth include the rising prevalence of disorders requiring frequent blood transfusions, such as thalassemia, and the growing number of surgical procedures, including orthopedic and cardiac surgeries. Additionally, advancements in regenerative medicine and cell therapies, along with an aging population, are further propelling market demand.

The market is characterized by significant developments and strategic initiatives by key players. Companies like Terumo Blood and Cell Technologies and Grifols are expanding their manufacturing capabilities and introducing innovative products to enhance blood processing efficiency. The blood cell processors segment is anticipated to hold a significant market share, driven by the increasing number of blood donations and the need for efficient blood component separation. North America, particularly the United States, is expected to dominate the market due to the presence of numerous organizations involved in blood component distribution and a high number of blood donors. Despite challenges such as stringent regulations and high costs, the market is set to witness robust growth, supported by strategic collaborations, product launches, and technological advancements by leading industry players.

Explore More

Global Blood Processing Devices and Consumables Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Prevenlance of Infectious Disorders Involving Blood Transfusions and Surgical Treatment

      2. 1.2.2 Growing Number of Initiatives in Regenerative Medicine and Cell Therapies

      3. 1.2.3 Increasing Geriatric Population

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulations

      2. 1.3.2 High Cost of Blood Processing Devices

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Product

      1. 2.1.1 By Blood Processing Devices

        1. 2.1.1.1 Blood Bank Freezers

        2. 2.1.1.2 Blood Grouping Analyzers

        3. 2.1.1.3 Blood Warmer

        4. 2.1.1.4 Blood Cell Processers

        5. 2.1.1.5 Other Blood Processing Devices

      2. 2.1.2 By Blood Processing Consumables

        1. 2.1.2.1 Blood Bags

        2. 2.1.2.2 Blood Lancets

        3. 2.1.2.3 Vials

        4. 2.1.2.4 Blood Administration Sets

        5. 2.1.2.5 Other Blood Processing Consumables

    2. 2.2 By End User

      1. 2.2.1 Hospitals and Clinics

      2. 2.2.2 Diagnostic Laboratories

      3. 2.2.3 Other End Users

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Global Blood Processing Devices and Consumables Market Size FAQs

The Global Blood Processing Devices and Consumables Market is projected to register a CAGR of greater than 6.5% during the forecast period (2024-2029)

Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Terumo Corporation and Macopharma are the major companies operating in the Global Blood Processing Devices and Consumables Market.

Blood Processing Devices and Consumables Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)